NCNMGF
PASG icon

Nano-Cap New Millennium Growth Fund’s Passage Bio PASG Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$118K – 172
2025
Q4 		$118K Buy
+10,000
New +$86.3K 0.1% 141

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's PASG Position: Q1 2026 in Review

Nano-Cap New Millennium Growth Fund sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 10,000 shares — an estimated $118K sold.

Nano-Cap New Millennium Growth Fund first reported a position in PASG in Q4 2025 and held it in 1 quarter. The position peaked at $118K in Q4 2025. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Nano-Cap New Millennium Growth Fund reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
  • Nano-Cap New Millennium Growth Fund sold 10,000 Passage Bio shares in Q1 2026, an estimated $118K.
  • Nano-Cap New Millennium Growth Fund first reported a position in Passage Bio in Q4 2025 and held it in 1 quarter.
  • Nano-Cap New Millennium Growth Fund's Passage Bio position peaked at $118K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q1 2026, filed 15 May 2026.